Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aditxt Inc (NQ: ADTX )

0.9100 +0.0100 (+1.11%)
Streaming Delayed Price Updated: 3:58 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,871
Open 0.9101
Bid (Size) 0.8800 (2)
Ask (Size) 0.9500 (50)
Prev. Close 0.9000
Today's Range 0.8801 - 0.9555
52wk Range 0.8800 - 28.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Researchers ID Substance That Could Make Autoimmune Disease Treatment Possible
Via Investor Brand Network
How Research on Blood Cancer Could Benefit the Organ Transplant Field
Via Investor Brand Network

Performance

YTD
-42.41%
-42.41%
1 Month
-25.41%
-25.41%
3 Month
-22.88%
-22.88%
6 Month
-78.28%
-78.28%
1 Year
-96.05%
-96.05%

More News

Read More
FDA Issues Warning about Reliability of Food Allergy Skin Tests
Via Investor Brand Network
Exposures Product Safety
TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Appoints Veteran of Media Industry as Chief Content, Engagement Officer
Via Investor Brand Network
Research Explains Why MS Patients Benefit from Stem Cell Transplants
Via Investor Brand Network
Aditxt Names Media Industry Veteran Maureen Connolly as Chief Content and Engagement Officer
From Aditxt, Inc.
Via Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Retains Top Banking Firm to Support Growth, Revenue-Generating Strategy
Via Investor Brand Network
Aditxt Retains Riverside Management Group as Advisor to Support Strategic M&A Driven Acquisitions by Subsidiary Pearsanta, Inc.
From Aditxt, Inc.
Via Business Wire
Study Finds Organ Transplant Recipients Undervaccinated
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Consuming Too Much Salt May Trigger Autoimmune Illnesses
Via Investor Brand Network
TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Forms US-Based Subsidiary with Focus to Expand Innovation Platforms
Via Investor Brand Network
Aditxt Forms its Second Subsidiary, Pearsanta, Inc., to Accelerate the Growth of its AditxtScore™ Program and Appoints Healthcare Executive and Current Head of AditxtScore™ Anthony Voorhies to Serve as its President
From Aditxt, Inc.
Via Business Wire
Food Allergies Worsen Cost of Living for Impacted Individuals
Via Investor Brand Network
Topics Economy
Exposures Interest Rates Supply Chain
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Reaches Pivotal Milestone to Advance ADI (TM) Technology
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Dedicated to New Era of Precision Medicine
Via Investor Brand Network
Aditxt, Inc. (NASDAQ: ADTX) Bolsters Goal to Conduct First-In-Human Clinical Trial Evaluating ADI(TM) Tech with Formation of Adimune, Inc. Subsidiary; Appoints Industry Veteran as Subsidiary Chairman and CEO
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Forms Subsidiary with Focus on Immune Modulation Therapies
Via Investor Brand Network
Aditxt Forms Adimune, Inc. as a Wholly Owned Subsidiary with a Focus on Immune Modulation Therapies and Appoints Dr. Friedrich Kapp, Former President of the Therapeutic Business Unit at Schering AG, as its Chairman and CEO
From Aditxt, Inc.
Via Business Wire
Aditxt Inc. (NASDAQ: ADTX) Announces Goal of First-in-Human Trials for Drug Candidate ADI(TM)-100 with a Focus on Psoriasis
Via Investor Brand Network
Researchers Look to AI to Improve Organ Transplant Processes
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Featured in Equity Research Reports
Via Investor Brand Network
Exposures COVID-19
Department of Defense Awards Scientists at University of Buffalo $4M Grant to Study Concussion Treatment
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.